The main pharmacological component of Injectable Inflammatory Suxunin is Inflammatory Suxunin, which can inhibit early capillary permeability increase and inflammatory exudation and edema, can specifically excite the pituitary adrenocortical function, promote the release of ACTH, and increase the biosynthesis of ACTH in the anterior pituitary, and in vitro it has the effect of inactivation of adenovirus, influenza virus, respiratory viruses, and other viruses, and it is suitable for viral pneumonia and viral upper respiratory tract infections. It is suitable for viral pneumonia and viral upper respiratory tract infections. Clinical application of Yansuning occasionally see allergic reactions such as skin rash or pyrogen-like reactions. Allergic to the product and pregnant women are prohibited.